Mar 26, 2024 / 08:30PM GMT
Operator
Greetings, and welcome to the BioAtla's fourth quarter and full year 2023 earnings call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to introduce your host, Bruce Mackle with LifeSci Advisors. Thank you. Mr. Michael, you may begin.
Bruce Mackle - LifeSci Advisors LLC - Moderator
Thank you, operator, and good afternoon, everyone. With me today on the phone from BioAtla are Dr. Jay Short, Chairman, CEO, and Co-Founder; and Richard Waldron, Chief Financial Officer. Following today's call, Dr. Eric Sievers, Chief Medical Officer; and Sheri Lydick, Chief Commercial Officer, will join Jay and Rich for a short Q&A. Earlier this afternoon, BioAmber released financial results and a business update for the fourth quarter and full year ended December 31, 2023.
A copy of the press release and corporate presentation are available on the Company's website and before we begin, I'd like
Q4 2023 Bioatla Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot